Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of FOLFOX6m plus SIR-Spheres vs FOLFOX6m alone in unresectable liver metastases from colorectal cancer
2008-003737-25Phase 4Completed
- Sponsor
- Sirtex
- Start
- Oct 2008
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxaliplatin, fluorouracil, folinic acid and yttrium-90 in metastatic colorectal adenocarcinoma (mCRC) and colorectal cancer (CRC) (2 arms), sponsored by Sirtex. Primary endpoints: Progression-free survival and Progression-free survival in the liver. Started Oct 2008; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acidyttrium-90
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)colorectal cancer (CRC)
Beyond the preview
Go deeper on 2008-003737-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003737-25.